Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 123

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration

Ohlemacher, Sarah K., Sridhar, Akshayalakshmi, Xiao, Yucheng, Hochstetler, Alexandra E., Sarfarazi, Mansoor, Cummins, Theodore R., Meyer, Jason S. · 2016 · Stem Cells

Abstract

Human pluripotent stem cells (hPSCs), including both embryonic and induced pluripotent stem cells, possess the unique ability to readily differentiate into any cell type of the body, including cells of the retina. Although previous studies have demonstrated the ability to differentiate hPSCs to a retinal lineage, the ability to derive retinal ganglion cells (RGCs) from hPSCs has been complicated by the lack of specific markers with which to identify these cells from a pluripotent source. In the current study, the definitive identification of hPSC-derived RGCs was accomplished by their directed, stepwise differentiation through an enriched retinal progenitor intermediary, with resultant RGCs expressing a full complement of associated features and proper functional characteristics. These results served as the basis for the establishment of induced pluripotent stem cells (iPSCs) from a patient with a genetically inherited form of glaucoma, which results in damage and loss of RGCs. Patient-derived RGCs specifically exhibited a dramatic increase in apoptosis, similar to the targeted loss of RGCs in glaucoma, which was significantly rescued by the addition of candidate neuroprotective factors. Thus, the current study serves to establish a method by which to definitively acquire and identify RGCs from hPSCs and demonstrates the ability of hPSCs to serve as an effective in vitro model of disease progression. Moreover, iPSC-derived RGCs can be utilized for future drug screening approaches to identify targets for the treatment of glaucoma and other optic neuropathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/stem.2356

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 62

  1. Keller, 2005, Embryonic stem cell differentiation: Emergence of a new era in biology and medicine, Genes Dev, 19, 1129, 10.1101/gad.1303605 · DOI · Paper page
  2. Pera, 2004, Human embryonic stem cells: Prospects for development, Development, 131, 5515, 10.1242/dev.01451 · DOI · Paper page
  3. Marchetto, 2011, Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises, Hum Mol Genet, 20, R109, 10.1093/hmg/ddr336 · DOI · Paper page
  4. Meyer, 2011, Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment, Stem Cells, 29, 1206, 10.1002/stem.674 · DOI · Paper page
  5. Singh, 2013, iPS cell modeling of Best disease: Insights into the pathophysiology of an inherited macular degeneration, Hum Mol Genet, 22, 593, 10.1093/hmg/dds469 · DOI · Paper page
  6. Mattis, 2015, HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity, Hum Mol Genet, 24, 3257, 10.1093/hmg/ddv080 · DOI
  7. Yoshida, 2014, The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa, Mol Brain, 7, 45, 10.1186/1756-6606-7-45 · DOI
  8. Jin, 2011, Modeling retinal degeneration using patient-specific induced pluripotent stem cells, PloS One, 6, e17084, 10.1371/journal.pone.0017084 · DOI · Paper page
  9. Schwarz, 2015, Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells, Hum Mol Genet, 24, 972, 10.1093/hmg/ddu509 · DOI
  10. Burnight, 2014, CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype, Gene Ther, 21, 662, 10.1038/gt.2014.39 · DOI
  11. Lamba, 2010, Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells, PloS One, 5, e8763, 10.1371/journal.pone.0008763 · DOI · Paper page
  12. Meyer, 2009, Modeling early retinal development with human embryonic and induced pluripotent stem cells, Proc Natl Acad Sci USA, 106, 16698, 10.1073/pnas.0905245106 · DOI · Paper page
  13. Ohlemacher, 2015, Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells, Current Protoc Stem Cell Biol, 32, 1h.8.1, 10.1002/9780470151808.sc01h08s32 · DOI
  14. Osakada, 2008, Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells, Nat Biotechnol, 26, 215, 10.1038/nbt1384 · DOI · Paper page
  15. Sridhar, 2013, Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells, Stem cells Transl Med, 2, 255, 10.5966/sctm.2012-0101 · DOI
  16. Lamba, 2006, Efficient generation of retinal progenitor cells from human embryonic stem cells, Proc Natl Acad Sci USA, 103, 12769, 10.1073/pnas.0601990103 · DOI · Paper page
  17. Boucherie, 2013, Brief report: Self-organizing neuroepithelium from human pluripotent stem cells facilitates derivation of photoreceptors, Stem Cells, 31, 408, 10.1002/stem.1268 · DOI
  18. Cedrone, 2008, Epidemiology of primary glaucoma: Prevalence, incidence, and blinding effects, Prog Brain Res, 173, 3, 10.1016/S0079-6123(08)01101-1 · DOI · Paper page
  19. Maekawa, 2015, Optimized culture system to induce neurite outgrowth from retinal ganglion cells in three-dimensional retinal aggregates differentiated from mouse and human embryonic stem cells, Curr Eye Res, 1, 10.3109/02713683.2015.1038359 · DOI
  20. Phillips, 2012, Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses, Invest Ophthalmol Vis Sci, 53, 2007, 10.1167/iovs.11-9313 · DOI · Paper page
  21. Riazifar, 2014, Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells, Stem Cells Transl Med, 3, 424, 10.5966/sctm.2013-0147 · DOI
  22. Tanaka, 2015, Generation of retinal ganglion cells with functional axons from human induced pluripotent stem cells, Sci Rep, 5, 8344, 10.1038/srep08344 · DOI
  23. Tucker, 2014, Duplication of TBK1 stimulates autophagy in iPSC-derived retinal cells from a patient with normal tension glaucoma, J Stem Cell Res Ther, 3, 161
  24. Velte, 1999, Action potentials in the dendrites of retinal ganglion cells, J Neurophysiol, 81, 1412, 10.1152/jn.1999.81.3.1412 · DOI
  25. Allingham, 2009, The genetics of primary open-angle glaucoma: A review, Exp Eye Res, 88, 837, 10.1016/j.exer.2008.11.003 · DOI · Paper page
  26. Fingert, 2011, Primary open-angle glaucoma genes, Eye, 25, 587, 10.1038/eye.2011.97 · DOI · Paper page
  27. Sarfarazi, 2003, Optineurin in primary open angle glaucoma, Ophthalmology clinics of North America., 16, 529, 10.1016/S0896-1549(03)00061-0 · DOI
  28. Rezaie, 2002, Adult-onset primary open-angle glaucoma caused by mutations in optineurin, Science, 295, 1077, 10.1126/science.1066901 · DOI · Paper page
  29. Sarfarazi, 2003, Genetics and biochemistry of primary congenital glaucoma, Ophthalmol Clin North Am, 16, 543, 10.1016/S0896-1549(03)00062-2 · DOI
  30. Ying, 2012, Cellular and molecular biology of optineurin, Int Rev Cell Mol Biol, 294, 223, 10.1016/B978-0-12-394305-7.00005-7 · DOI · Paper page
  31. Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
  32. Sridhar, 2016, Robust differentiation of mrna-reprogrammed human induced pluripotent stem cells toward a retinal lineage, Stem Cells Transl Med, 10.5966/sctm.2015-0093 · DOI
  33. Phillips, 2014, Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for visual system homeobox 2, Stem Cells, 32, 1480, 10.1002/stem.1667 · DOI
  34. Park, 2006, Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types, Am J Pathol, 169, 1976, 10.2353/ajpath.2006.060400 · DOI · Paper page
  35. Turturro, 2014, Effects of mutations and deletions in the human optineurin gene, SpringerPlus, 3, 99, 10.1186/2193-1801-3-99 · DOI
  36. Ying, 2010, Posttranslational modifications, localization, and protein interactions of optineurin, the product of a glaucoma gene, PloS One, 5, e9168, 10.1371/journal.pone.0009168 · DOI
  37. Rowe, 2013, Voltage-gated sodium channel in grasshopper mice defends against bark scorpion toxin, Science, 342, 441, 10.1126/science.1236451 · DOI
  38. Chambers, 2012, Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors, Nat Biotechnol, 30, 715, 10.1038/nbt.2249 · DOI · Paper page
  39. Finlay, 2008, The developing and evolving retina: Using time to organize form, Brain Res, 1192, 5, 10.1016/j.brainres.2007.07.005 · DOI
  40. Livesey, 2001, Vertebrate neural cell-fate determination: Lessons from the retina. Nature reviews, Neuroscience, 2, 109
  41. Rollag, 2003, Melanopsin, ganglion-cell photoreceptors, and mammalian photoentrainment, J Biol Rhythms, 18, 227, 10.1177/0748730403018003005 · DOI
  42. Sand, 2012, Diverse types of ganglion cell photoreceptors in the mammalian retina, Prog Retin Eye Res, 31, 287, 10.1016/j.preteyeres.2012.03.003 · DOI
  43. Erskine, 2007, The retinal ganglion cell axon's journey: Insights into molecular mechanisms of axon guidance, Dev Biol, 308, 1, 10.1016/j.ydbio.2007.05.013 · DOI · Paper page
  44. Erskine, 2014, Connecting the retina to the brain, ASN Neuro, 6, 10.1177/1759091414562107 · DOI · Paper page
  45. Egawa, 2012, Drug screening for ALS using patient-specific induced pluripotent stem cells, Sci Transl Med, 4, 145ra104, 10.1126/scitranslmed.3004052 · DOI · Paper page
  46. Corti, 2015, Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery, Expert Opin Drug Discov, 10, 615, 10.1517/17460441.2015.1037737 · DOI
  47. Ko, 2014, Concise review: Drug discovery in the age of the induced pluripotent stem cell, Stem Cells Transl Med, 3, 500, 10.5966/sctm.2013-0162 · DOI
  48. Horsford, 2005, Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity, Development, 132, 177, 10.1242/dev.01571 · DOI · Paper page
  49. Almeida, 2005, Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways, Cell Death Differ, 12, 1329, 10.1038/sj.cdd.4401662 · DOI · Paper page
  50. Vigneswara, 2013, Pigment epithelium-derived factor is retinal ganglion cell neuroprotective and axogenic after optic nerve crush injury, Invest Ophthalmol Vis Sci, 54, 2624, 10.1167/iovs.13-11803 · DOI
  51. Alsina, 2001, Visualizing synapse formation in arborizing optic axons in vivo: Dynamics and modulation by BDNF, Nat Neurosci, 4, 1093, 10.1038/nn735 · DOI · Paper page
  52. Hu, 2010, Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells, Invest Ophthalmol Vis Sci, 51, 1747, 10.1167/iovs.09-4450 · DOI
  53. Pang, 2007, Pigment epithelium-derived factor protects retinal ganglion cells, BMC Neurosci, 8, 11, 10.1186/1471-2202-8-11 · doi:10.1186/1471-2202-8-11
  54. Tombran-Tink, 2003, Therapeutic prospects for PEDF: More than a promising angiogenesis inhibitor, Trends Mol Med, 9, 244, 10.1016/S1471-4914(03)00074-1 · DOI
  55. Badea, 2011, Morphologies of mouse retinal ganglion cells expressing transcription factors Brn3a, Brn3b, and Brn3c: Analysis of wild type and mutant cells using genetically-directed sparse labeling, Vision Res, 51, 269, 10.1016/j.visres.2010.08.039 · DOI
  56. Nadal-Nicolas, 2012, Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats, PloS one., 7, e49830, 10.1371/journal.pone.0049830 · DOI
  57. Esquiva, 2013, Impairment of intrinsically photosensitive retinal ganglion cells associated with late stages of retinal degeneration, Invest Ophthalmol Vis Sci, 54, 4605, 10.1167/iovs.13-12120 · DOI
  58. Qu, 2010, Mechanisms of retinal ganglion cell injury and defense in glaucoma, Exp Eye Res, 91, 48, 10.1016/j.exer.2010.04.002 · DOI · Paper page
  59. Bagga, 2009, Intraocular pressure measurements throughout the 24 h, Curr Opin Ophthalmol, 20, 79, 10.1097/ICU.0b013e32831eef4f · doi:10.1097/icu.0b013e32831eef4f
  60. Tseng, 2015, Visual impairment in an optineurin mouse model of primary open-angle glaucoma, Neurobiol Aging, 36, 2201, 10.1016/j.neurobiolaging.2015.02.012 · DOI · Paper page
  61. Sengupta, 2011, Control of organelle size: The Golgi complex, Annu Rev cell Dev Biol, 27, 57, 10.1146/annurev-cellbio-100109-104003 · DOI
  62. Shorter, 2002, Golgi architecture and inheritance, Annu Rev Cell Dev Biol, 18, 379, 10.1146/annurev.cellbio.18.030602.133733 · DOI · Paper page

Cited by

See all 123

Metadata

Authors
Ohlemacher, S. K., Sridhar, A., Xiao, Y., Hochstetler, A. E., Sarfarazi, M., Cummins, T. R., & Meyer, J. S.
Venue
Stem Cells
Published
2016-03-21
Volume
34
Issue
6
Pages
1553-1562
ISSN
  • 1066-5099
  • 1549-4918
Cited by
123
References
11
Language
en
Funders
  • NIH (R01 EY024984, R01 NS053422)
  • BrightFocus foundation (G201027)
  • Office of the Vice Chancellor for Research at IUPUI
  • ICTSI NIH/NCRR (TL1TR001107, UL1TR001108)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.